194 related articles for article (PubMed ID: 31070981)
1. Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer.
Honda K; Gyawali B; Ando M; Kumanishi R; Kato K; Sugiyama K; Mitani S; Masuishi T; Narita Y; Bando H; Taniguchi H; Kadowaki S; Ura T; Muro K
J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31070981
[TBL] [Abstract][Full Text] [Related]
2. A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
Honda K; Gyawali B; Ando M; Sugiyama K; Mitani S; Masuishi T; Narita Y; Taniguchi H; Kadowaki S; Ura T; Muro K
Ecancermedicalscience; 2018; 12():847. PubMed ID: 30079109
[TBL] [Abstract][Full Text] [Related]
3. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
Jing J; Feng R; Zhang X; Li M; Gao J
Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
[TBL] [Abstract][Full Text] [Related]
4. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
[TBL] [Abstract][Full Text] [Related]
6. Understanding financial toxicity in head and neck cancer survivors.
Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
[TBL] [Abstract][Full Text] [Related]
7. Financial toxicity assessment and associated factors analysis of patients with cancer in China.
Qiu Z; Yao L; Jiang J
Support Care Cancer; 2023 Apr; 31(5):264. PubMed ID: 37058171
[TBL] [Abstract][Full Text] [Related]
8. [Measuring Financial Toxicity in Japanese Cancer Patients].
Honda K
Gan To Kagaku Ryoho; 2018 May; 45(5):785-788. PubMed ID: 30026437
[TBL] [Abstract][Full Text] [Related]
9. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
10. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
[TBL] [Abstract][Full Text] [Related]
11. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
McLean L; Hong W; McLachlan SA
Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.
Yap SL; Wong SS; Chew KS; Kueh JS; Siew KL
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3077-3083. PubMed ID: 33112570
[TBL] [Abstract][Full Text] [Related]
13. The financial impact of cancer care on renal cancer patients.
Ezeife DA; Morganstein BJ; Yip S; Ryan M; Law JH; Guan AY; Le LW; Hansen AR; Sacher A; Bjarnason GA; Doherty MK; Leighl NB
Can J Urol; 2021 Aug; 28(4):10762-10767. PubMed ID: 34378512
[TBL] [Abstract][Full Text] [Related]
14. Financial toxicity of patients with lung cancer in China: Results from a National Survey Study.
Liu M; Huang D; Liu Y
Cancer Med; 2023 Feb; 12(4):4751-4760. PubMed ID: 36128854
[TBL] [Abstract][Full Text] [Related]
15. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
[TBL] [Abstract][Full Text] [Related]
16. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689
[TBL] [Abstract][Full Text] [Related]
19. Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry.
Mollica MA; Zaleta AK; Gallicchio L; Brick R; Jacobsen PB; Tonorezos E; Castro KM; Miller MF
Support Care Cancer; 2024 Jan; 32(2):137. PubMed ID: 38286846
[TBL] [Abstract][Full Text] [Related]
20. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
Ezeife DA; Morganstein BJ; Lau S; Law JH; Le LW; Bredle J; Cella D; Doherty MK; Bradbury P; Liu G; Sacher A; Shepherd FA; Leighl NB
Clin Lung Cancer; 2019 Jul; 20(4):231-236. PubMed ID: 30797721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
